Rani Therapeutics Holdings, Inc.RANINASDAQ

52-Week Range0-4

0.39Current 1.133.87

Want to monitor RANI?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs.

Professional, Scientific, and Technical Services

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Wall Street Week Ahead

Prediction: Pivoting Away From Metaverse Will Help Meta's Stock Long Term

3 Genius Artificial Intelligence (AI) Stocks You'll Regret Not Buying Now

LAC Stock Up 32% Over the Past Year But Share Dilution Is Quietly Piling Up

FirstService: Excellent Growth Story Currently On Sale

War and Inflation Are Supposed to Be Gold's Friends. Not This Time.

How Amazon Is Bringing Fast Delivery to Rural America

Best Dividend Stocks to Buy Right Now for Passive Income

China's Sinopec posts 36.8% drop in 2025 net profit on weak petrochemical margins, new energy substitution

2 Magnificent S&P 500 Dividend Stocks Down as Much as 25% to Buy and Hold Forever

Should You Buy Eli Lilly Stock Before April 10?

The Best Stocks to Invest $1,000 in After Last Week's Market Volatility

UCO Is Up 125% This Year but a Hidden Structural Risk Could Erase the Gains

I Was Shocked at Who Is Now Running Berkshire Hathaway's $308 Billion Stock Portfolio

Warren Buffett's Warning to Wall Street Is Echoing Louder Than Ever: 3 Steps Investors Should Take Now

3 High-Yield Dividend Stocks I'd Buy Right Now With No Hesitation

Dauch Corporation Board Director Buys 35,000 Shares After Company Completes Major Acquisition

2 AI Stocks to Buy Before They Soar 80% and 50%, According to Wall Street Analysts

Up 51% in 2 Years, Is This the Best Tech Stock to Buy Right Now?

The Ultimate Dividend Growth Stock to Buy With $1,000 Right Now

About